Previous studies have mainly focused on associations between low PSA concentrations and disease progression and prognosis in prostate cancer patients with high GS (Aggarwal et al., 2021; Mahal et al., 2016, 2018). This evidence concerns the gene KLK3 and prostate carcinoma.